"Therefore, dietary supplementation of DHA in food is an effective method for reducing the risk of CHD in people who do not frequently eat fish,” the researchers stated.
DHA-enriched bread rolls effectively reduced blood pressure and lipid profiles in men with hypertension and high cholesterol, according to a new study published in the International Journal of Hypertension.
Fifty-six hypertensive and/or hypercholesterolemic men were randomly assigned to receive either 2 g/day of docosahexaenoic acid (DHA) omega-3 fatty acid or 1 g/day of olive oil. The oils were incorporated in bread rolls, which the subjects ate on alternate days for five weeks.
After the study’s completion, researchers examined 38 of the subjects and found that men who ate the DHA-infused rolls showed significant reductions in systolic and diastolic blood pressure, as well as heart rate, when compared to baseline. The olive oil subject saw benefits also, but not ones that reached statistical significance.
Regarding cholesterol, the DHA group saw significant increases in high-density lipoprotein (HDL) cholesterol and significant decreases in ratios total cholesterol:HDL cholesterol and non-HDL cholesterol:HDL cholesterol compared to baseline.
“In this randomized, double-blind, placebo-controlled study, supplementation of DHA incorporated into bread rolls significantly reduced multiple independent risk factors for CHD in men with hypertension and/or hypercholesterolemia. Therefore, dietary supplementation of DHA in food is an effective method for reducing the risk of CHD in people who do not frequently eat fish,” the researchers stated.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.